SCHEMBL24899530

SCHEMBL24899530

c1ccc(-c2ccc(N(c3ccc4ccccc4c3)c3cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)cc4oc5ccccc5c34)cc2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.34
ALDH1A1 P00352 3/20 0.34
CYP1A2 P05177 3/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
KMT2A Q03164 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MEN1 O00255 1/20 0.34
TP53 P04637 1/20 0.34
CCR4 P51679 1/20 0.32
TSHR P16473 4/20 0.32
POLB P06746 2/20 0.32
TERT O14746 2/20 0.31
KDM1A O60341 1/20 0.31
MAPT P10636 4/20 0.31
LMNA P02545 3/20 0.31
GLA P06280 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
HPGD P15428 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24255633 0.97 CYP1A2 (0.33) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A
SCHEMBL22112385 0.97 CYP1A2 (0.38) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A
SCHEMBL24899529 0.97 KDM4E (0.34) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A
SCHEMBL24066167 0.96 KDM4E (0.37) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A
SCHEMBL22112382 0.93 TSHR (0.35) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A
SCHEMBL22112392 0.93 TSHR (0.35) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A
SCHEMBL22112381 0.93 TSHR (0.35) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A
SCHEMBL22112395 0.93 TSHR (0.35) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A
SCHEMBL24066137 0.92 ALDH1A1 (0.34) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A
SCHEMBL22112697 0.91 TSHR (0.35) KDM4EALDH1A1CYP1A2SMN1; SMN2KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230016632-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO.,LTD. (KR) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230016632-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE, AND METHOD FOR MANUFACTURING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, CYP1B1, CRY1 KDM4E 3329/4885ALDH1A1 23/4885CYP1A2 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.